dimarts, 28 d’abril del 2015

FDA closes out CryoLife warning letter, PerClot trial launches

CryoLife says the FDA closed out a 2013 warning letter sent over problems at a Georgia plant and announces the launch of a clinical trial for its PerClot surgical hemostasis powder.

FDA closes out CryoLife warning letter, PerClot trial launches

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Ij7cOx

Cap comentari:

Publica un comentari a l'entrada